Resources for researchers
During the first year of the pandemic, Karolinska Institutet's researchers have published almost 600 scientific articles related to COVID-19, and there are currently some 350 ongoing research projects in this field at our university. On this page, we continually gather information about resources that are of interest to researchers working with COVID-19 or related areas. Please let us know if anything should be added.
National portal for COVID-19 research
National portal for COVID-19 research
The Swedish COVID-19 Data Portal provides information, guidelines, tools and services to support researchers in utilising Swedish and European infrastructures for data sharing, in particular the European COVID-19 Data Portal. The Swedish portal is coordinated by SciLifeLab and the Swedich Research Council.
SciLifeLab prioritise COVID-19 projects
SciLifeLab prioritise COVID-19 projects
The national, government-funded research infrastructure SciLifeLab are now prioritising projects regarding the new coronavirus and COVID-19. Contact them and find out more.
Resource teams for support during the pandemic
Resource teams for support during the pandemic
President Ole Petter Ottersen has set up a number of resource teams to bring together internal experts at KI to aid the university management and to help in our internal and external communication.
Research funding during the pandemic
Research funding during the pandemic
Research funding-bodies around the world are mobilising in the fight against SARS-CoV-2. Grants Office at KI will keep you updated on new grant announcements and changed terms in ongoing funding as a result of the COVID-19 pandemic.
The “known unknowns” of T cell immunity
The “known unknowns” of T cell immunity
In a new perspective article in Science Immunology, researchers at KI shed light on important questions that need to be answered in order to increase our understanding of the role of T cell immunity in acute and convalescent COVID-19 infection.
Biosafety level 3 labs ready for SARS-CoV-2
The COVID-19 Immune Atlas
The COVID-19 Immune Atlas
The Karolinska KI/K COVID-19 Immune Atlas aims to provide a comprehensive overview of the human immune response in COVID-19 disease, freely available for scientists in academia, other organisations, and industry.
SARS-CoV-2 related proteins
SARS-CoV-2 related proteins
The Human Protein Atlas is a Swedish-based project with the aim to map all the human proteins in cells, tissues and organs using integration of various omics technologies. KI is a partner in this effort, which now also lists proteins related to SARS-Cov-2.
Good to know about clinical trials
Clinical trial registration and reporting at Karolinska Institutet
Clinical trial registration and reporting at Karolinska Institutet
KI has centralised the process for registering and reporting results for clinical trials and clinical studies. The Compliance and Data Office (CDO) is responsible for this task and offers information and support to researchers.
Clinical trials during the COVID-19 pandemic
Clinical trials during the COVID-19 pandemic
The Swedish Medical Products Agency has collected useful information for researchers about conducing clinical trials during the pandemic. Please note that you might have to apply for permission for studies evaluating the effects of COVID-19 vaccination.
Clinical trials in Sweden step by step
Clinical trials in Sweden step by step
This website presents useful links for guidance and support for clinical research, for example compilations of approved ethics applications and databases with ongoing clinical studies on covid-19. The information is administered by the Swedish Research Council.
Karolinska Trial alliance
Karolinska Trial alliance
KTA offers courses and services throughout the whole research process of clinical trials at a self-cost price. This service is a part of Karolinska University Hospital with the aim of supporting both academia and industry within the Stockholm-Gotland Region.
Meet other experts
Digital meeting-spot for COVID-19 researchers
Digital meeting-spot for COVID-19 researchers
The digital innovation platform Crowdhelix Network has started an international meeting spot for researchers and companies ready to tackle the ongoing pandemic. The COVID-19 group within Crowdhelix is led by Karolinska Institutet.
ScienceBusiness Coronavirus Gateway
ScienceBusiness Coronavirus Gateway
The Coronavirus R&D Gateway is a resource for researchers, companies, policymakers and the interested public at large. It has been created in cooperation with several partner organisations, including Karolinska Institutet.